CD34 and myelodysplastic syndrome: Immunophenotypic profiles of HSPC subpopulations were examined in BM samples of 10 newly diagnosed CD34+/CD38− AML patients, 6 patients with myelodysplastic syndromes (MDS) (Table S1), and 7 healthy donors (HDs) (Figure 1A–D).